121 related articles for article (PubMed ID: 3935372)
21. Norplant: subdermal implant system for long-term contraception.
Shoupe D; Mishell DR
Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1286-92. PubMed ID: 2497646
[TBL] [Abstract][Full Text] [Related]
22. Effects of continuous levonorgestrel treatment (subcutaneous capsules) on the lipoprotein and carbohydrate metabolism in fertile women.
Lithell H; Weiner E; Vessby B; Johansson ED
Ups J Med Sci; 1983; 88(2):103-8. PubMed ID: 6417867
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the effects of NORPLANT capsules and NORPLANT-2 rods on clinical chemistry: metabolic changes.
Singh K; Viegas OA; Ratnam SS
Ann Acad Med Singap; 1990 Nov; 19(6):833-6. PubMed ID: 2130749
[TBL] [Abstract][Full Text] [Related]
24. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
25. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
26. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
Singh K; Viegas OA; Loke DF; Ratnam SS
Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
[TBL] [Abstract][Full Text] [Related]
27. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonic visualization of NORPLANT subdermal contraceptive devices.
Thomsen RJ; Pasquale S; Nosher J
Int J Gynaecol Obstet; 1985 Jun; 23(3):223-7. PubMed ID: 2865186
[TBL] [Abstract][Full Text] [Related]
29. Hormonal implants: contraception for a new century.
Darney PD
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS
Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546
[TBL] [Abstract][Full Text] [Related]
31. Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction.
Hingorani V; Jalnawala SF; Kochhar M; Rai Chaudhury G; Sengupta PC; Datey S; Mehta S; Roy M; Saxena NC; Saxena BN
Contraception; 1986 Mar; 33(3):233-44. PubMed ID: 3087694
[TBL] [Abstract][Full Text] [Related]
32. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
33. Serum lipids in Norplant implants users: a cross-sectional study.
Affandi B; Suherman SK; Djajalelana ; Prihartono DJ; Lubis F; Samil RS
Contraception; 1987 Oct; 36(4):429-34. PubMed ID: 3127112
[TBL] [Abstract][Full Text] [Related]
34. Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
Kloosterboer HJ; van Wayjen RG; van den Ende A
Contraception; 1986 Aug; 34(2):135-44. PubMed ID: 2946552
[TBL] [Abstract][Full Text] [Related]
35. Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids--a randomized comparative study.
Biswas A; Viegas OA; Roy AC
Contraception; 2003 Sep; 68(3):189-93. PubMed ID: 14561539
[TBL] [Abstract][Full Text] [Related]
36. Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
Shaaban MM; Salem HT; Abdullah KA
Contraception; 1985 Dec; 32(6):623-35. PubMed ID: 3937665
[TBL] [Abstract][Full Text] [Related]
37. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
38. Release rates of levonorgestrel from Silastic capsules, homogeneous rods and covered rods in humans.
Robertson DN; Sivin I; Nash HA; Braun J; Dinh J
Contraception; 1983 May; 27(5):483-95. PubMed ID: 6411428
[TBL] [Abstract][Full Text] [Related]
39. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
Affandi B; Cekan SZ; Boonkasemsanti W; Samil RS; Diczfalusy E
Contraception; 1987 Feb; 35(2):135-45. PubMed ID: 3109803
[TBL] [Abstract][Full Text] [Related]
40. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
